Target- |
MechanismChelating agents |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date05 Sep 2017 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date06 Jul 2017 |
100 Clinical Results associated with Jace Pharma Pty Ltd.
0 Patents (Medical) associated with Jace Pharma Pty Ltd.
100 Deals associated with Jace Pharma Pty Ltd.
100 Translational Medicine associated with Jace Pharma Pty Ltd.